Chronic rhinosinusitis (CRS) is a multifactorial inflammatory disease. The role of genetic variations of related genes in the development of CRS and severity of symptoms is unknown in Southwestern Chinese populations.
Objective
We selected candidate CRS-related genetic polymorphisms and evaluated the associations that were different according to the presence of nasal polyp, asthma, and allergic rhinitis (AR) in a Southwestern Chinese population. Detailed phenotypes were compared among different genotypes.
Methods
In 452 CRS patients and 591 healthy controls, clinico-epidemiological information was collected and 23 previously reported CRS-related single-nucleotide polymorphisms (SNPs) were genotyped. Genotypes were determined using a Sequenom MassARRAY SNP genotyping system. Clinical disease measures including the sinonasal outcome test, visual analogue scale (VAS), and symptom severity VAS were evaluated for each patient. The association between CRS, genotypes, asthma, AR, and symptoms was analyzed. The effect of sex, age, body mass index, and status of smoking was considered.
Results
Statistically significant genotypic association with CRS was observed with an IL1RL1 genetic polymorphism (rs13431828; odds ratio [OR] = 1.45; 95% confidence interval [CI], 1.06–1.99; P = .02). Similar association was observed with rs13431828 in subgroups of CRS with nasal polyps (OR = 1.53; 95% CI, 1.03–2.29; P = .04), asthma (OR = 2.08; 95% CI, 1.14–3.79; P = .02), and AR (OR = 1.59; 95% CI, 1.06–2.39; P = .02). No significant association with other SNPs was observed. The evaluated genetic polymorphisms were not associated with clinical symptom scores.
Conclusion
This study replicated rs13431828 as being associated with CRS in Southwestern Chinese. rs13431828 was also significantly associated with CRS patients who have concurrent allergic nasal diseases.
ShiJBFuQLZhangH, et al.
Epidemiology of chronic rhinosinusitis: results from a cross-sectional survey in seven Chinese cities.Allergy. 2015;
70:533–539.
2.
FokkensWJLundVJMullolJ, et al.
European position paper on rhinosinusitis and nasal polyps 2012.Rhinol Suppl. 2012;
23:3 p preceding table of contents, 1–298.
3.
OrlandiRRKingdomTTHwangPH, et al.
International consensus statement on allergy and rhinology: rhinosinusitis.Int Forum Allergy Rhinol. 2016;
6(Suppl 1):S22–S209.
4.
BachertCZhangLGevaertP.Current and future treatment options for adult chronic rhinosinusitis: focus on nasal polyposis.J Allergy Clin Immunol. 2015;
136:1431–1440.
5.
WangXZhangNBoM, et al.
Diversity of TH cytokine profiles in patients with chronic rhinosinusitis: a multicenter study in Europe, Asia, and Oceania.J Allergy Clin Immunol. 2016;
138:1344–1353.
6.
HsuJPetersAT.Pathophysiology of chronic rhinosinusitis with nasal polyp.Am J Rhinol Allergy. 2011;
25:285–290.
7.
BachertCGevaertPHoltappelsGJohanssonSGvan CauwenbergeP.Total and specific IgE in nasal polyps is related to local eosinophilic inflammation.J Allergy Clin Immunol. 2001;
107:607–614.
8.
HsuJAvilaPCKernRCHayesMGSchleimerRPPintoJM.Genetics of chronic rhinosinusitis: state of the field and directions forward.J Allergy Clin Immunol. 2013;
131:977–993, 993.e1–993.e5.
9.
HenmyrVVandeplasGHalldenC, et al.
Replication study of genetic variants associated with chronic rhinosinusitis and nasal polyposis.J Allergy Clin Immunol. 2014;
133:273–275.
10.
ParkCSChoJHParkYJ.Toll-like receptor 2 gene polymorphisms in a Korean population: association with chronic rhinosinusitis.Otolaryngol Head Neck Surg. 2011;
144:96–100.
11.
WalleyAJCooksonWO.Investigation of an interleukin-4 promoter polymorphism for associations with asthma and atopy.J Med Genet. 1996;
33:689–692.
12.
NoguchiEShibasakiMArinamiT, et al.
Association of asthma and the interleukin-4 promoter gene in Japanese. Clin Exp Allergy. 1998;
28:449–453.
13.
CastanoRBosseYEndamLMDesrosiersM.Evidence of association of interleukin-1 receptor-like 1 gene polymorphisms with chronic rhinosinusitis.Am J Rhinol Allergy. 2009;
23:377–384.
14.
ZhangYEndamLMFilali-MouhimA, et al.
Polymorphisms in RYBP and AOAH genes are associated with chronic rhinosinusitis in a Chinese population: a replication study.PLoS One. 2012;
7:e39247.
15.
ZhangMLNiPHCaiCPChenNJWangS.[The association between genetic polymorphisms of IL-6 and the susceptibility of chronic rhinosinusitis].Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi.2012;
26:197–200, 204.
16.
BernsteinJMAnonJBRontalMConroyJWangCSuchestonL.Genetic polymorphisms in chronic hyperplastic sinusitis with nasal polyposis.Laryngoscope. 2009;
119:1258–1264.
17.
ErbekSSYurtcuEErbekSAtacFBSahinFICakmakO.Proinflammatory cytokine single nucleotide polymorphisms in nasal polyposis.Arch Otolaryngol Head Neck Surg. 2007;
133:705–709.
18.
Mfuna EndamLCormierCBosseYFilali-MouhimADesrosiersM.Association of IL1A, IL1B, and TNF gene polymorphisms with chronic rhinosinusitis with and without nasal polyposis: a replication study.Arch Otolaryngol Head Neck Surg. 2010;
136:187–192.
19.
KarjalainenJHulkkonenJPessiT, et al.
The IL1A genotype associates with atopy in nonasthmatic adults.J Allergy Clin Immunol. 2002;
110:429–434.
20.
KiltySJBosseYCormierCEndamLMDesrosiersMY.Polymorphisms in the SERPINA1 (alpha-1-antitrypsin) gene are associated with severe chronic rhinosinusitis unresponsive to medical therapy.Am J Rhinol Allergy. 2010;
24:e4–e9.
21.
Jimenez-MoralesSMartinez-AguilarNGamboa-BecerraR, et al.
Polymorphisms in metalloproteinase-9 are associated with the risk for asthma in Mexican pediatric patients.Hum Immunol. 2013;
74:998–1002.
22.
WangLFChienCYTaiCFKuoWRHsiEJuoSH.Matrix metalloproteinase-9 gene polymorphisms in nasal polyposis.BMC Med Genet. 2010;
11:85.
23.
BosseYBacotFMontpetitA, et al.
Identification of susceptibility genes for complex diseases using pooling-based genome-wide association scans.Hum Genet. 2009;
125:305–318.
24.
TournasAMfunaLBosseYFilali-MouhimAGrenierJPDesrosiersM.A pooling-based genome-wide association study implicates the p73 gene in chronic rhinosinusitis. J Otolaryngol Head Neck Surg. 2010;
39:188–195.
25.
PasajeCFBaeJSParkBL, et al.
DCBLD2 gene variations correlate with nasal polyposis in Korean asthma patients.Lung. 2012;
190:199–207.
26.
WuWLiZTangTWuJLiuFGuL.5-HTR2A and IL-6 polymorphisms and obstructive sleep apnea-hypopnea syndrome.Biomed Rep. 2016;
4:203–208.
27.
GaoTNgCLLiC, et al.
Smoking is an independent association of squamous metaplasia in Chinese nasal polyps.Int Forum Allergy Rhinol. 2016;
6:66–74.
28.
SchneiderAGantnerLMaagIBorstMMWensingMSzecsenyiJ.Are ICD-10 codes appropriate for performance assessment in asthma and COPD in general practice? Results of a cross sectional observational study.BMC Health Serv Res. 2005;
5:11.
29.
ZhangMTangXWangY, et al.
Variants of TLR1 associated with tuberculosis susceptibility in the Chinese Tibetan population but not in Han Chinese.Infect Genet Evol. 2018;
61:53–59.
30.
BasuSGeorgalasCKumarBNDesaiS.Correlation between symptoms and radiological findings in patients with chronic rhinosinusitis: an evaluation study using the Sinonasal Assessment Questionnaire and Lund-Mackay grading system.Eur Arch Otorhinolaryngol. 2005;
262:751–754.
31.
LundVJHolmstromMScaddingGK.Functional endoscopic sinus surgery in the management of chronic rhinosinusitis. An objective assessment.J laryngol Otol. 1991;
105:832–835.
32.
LundVJMackayIS.Staging in rhinosinusitus.Rhinology. 1993;
31:183–184.
33.
ChesterACAntisdelJLSindwaniR.Symptom-specific outcomes of endoscopic sinus surgery: a systematic review.Otolaryngol Head Neck Surg. 2009;
140:633–639.
34.
PalikheNSKimSHChoBY, et al.
IL-13 gene polymorphisms are associated with rhinosinusitis and eosinophilic inflammation in aspirin intolerant asthma.Allergy Asthma Immunol Res. 2010;
2:134–140.
35.
BuysschaertIDGruloisVEloyP, et al.
Genetic evidence for a role of IL33 in nasal polyposis.Allergy. 2010;
65:616–622.
FerreiraMAMcRaeAFMedlandSE, et al.
Association between ORMDL3, IL1RL1 and a deletion on chromosome 17q21 with asthma risk in Australia.Eur J Hum Genet. 2011;
19:458–464.
38.
Diaz-JimenezDNunezLDe la FuenteM, et al.
A functional IL1RL1 variant regulates corticosteroid-induced sST2 expression in ulcerative colitis.Sci Rep. 2017;
7:10180.
39.
XuDJiangHRKewinP, et al.
IL-33 exacerbates antigen-induced arthritis by activating mast cells.Proc Natl Acad Sci U S A. 2008;
105:10913–10918.
40.
SavenijeOEMahachie JohnJMGranellR, et al.
Association of IL33-IL-1 receptor-like 1 (IL1RL1) pathway polymorphisms with wheezing phenotypes and asthma in childhood.J Allergy Clin Immunol. 2014;
134:170–177.
41.
SavenijeOEKerkhofMReijmerinkNE, et al.
Interleukin-1 receptor-like 1 polymorphisms are associated with serum IL1RL1-a, eosinophils, and asthma in childhood.J Allergy Clin Immunol. 2011;
127:750–756.
42.
GTEx Consortium.
Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans.Science. 2015;
348:648–660.
43.
WestraHJPetersMJEskoT, et al.
Systematic identification of trans eQTLs as putative drivers of known disease associations.Nat Genet. 2013;
45:1238–1243.
44.
KondoYYoshimotoTYasudaK, et al.
Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system.Int Immunol. 2008;
20:791–800.
45.
SchmitzJOwyangAOldhamE, et al.
IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines.Immunity. 2005;
23:479–490.
46.
MoffattMFGutIGDemenaisF, et al.
A large-scale, consortium-based genomewide association study of asthma.N Engl J Med. 2010;
363:1211–1221.
47.
TorgersonDGAmplefordEJChiuGY, et al.
Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations. Nat Genet. 2011;
43:887–892.
48.
KamekuraRKojimaTTakanoKGoMSawadaNHimiT.The role of IL-33 and its receptor ST2 in human nasal epithelium with allergic rhinitis.Clin Exp Allergy. 2012;
42:218–228.
49.
DaleMNicklinMJ.Interleukin-1 receptor cluster: gene organization of IL1R2, IL1R1, IL1RL2 (IL-1Rrp2), IL1RL1 (T1/ST2), and IL18R1 (IL-1Rrp) on human chromosome 2q.Genomics. 1999;
57:177–179.
50.
GevaertPVan BruaeneNCattaertT, et al.
Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis.J Allergy Clin Immunol. 2011;
128:989–995.
51.
CastroMCorrenJPavordID, et al.
Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma.N Engl J Med. 2018;
378:2486–2496.
